A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...

The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...

A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...

Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...

REDWOOD CITY, CA, USA I March 31, 2025 I Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development ...

There is no national ovarian cancer screening programme as, according to the NHS, there is not a test that can reliably pick ...

In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis. Current CA-125 thresholds ...

In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated ...

The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients were 23% less likely to ...